Effect of Kashmaryadi Kwath Virechana in treatment of Vatarakta (Gout)
Phase 3
- Conditions
- Health Condition 1: M109- Gout, unspecified
- Registration Number
- CTRI/2022/11/047191
- Lead Sponsor
- Dr Sarvepalli Radhakrishnan Rajasthan, Ayurved University, Jodhpur
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1 Subjects presenting with clinical features of vatarakta.
2 Patient having chronicity less than 1 year.
3 Subjects of both sex between the age group of 20 to 60 years.
4 Patient having serum uric acid level above 5 mg/dl and presenting the sign and symptoms of vatarakta.
Exclusion Criteria
1 Subjects with uncontrolled metabolic disorders and other systemic disorders
2 Subjects with autoimmune diseases of joints
3 chronicity for more than 1 year.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Subjective Parameters <br/ ><br>1 Pain (Ruka) VAS Scale <br/ ><br>2 Burning Sensation (Daha) <br/ ><br>3 Malaise (Angmarda) <br/ ><br>4 Local Colour Changes in the Skin <br/ ><br> <br/ ><br>Objective Parameters <br/ ><br>1 Tenderness (Sparshasahyata) <br/ ><br>2 Edema (Shwayathu) <br/ ><br>3 Walking Ability <br/ ><br>4 Peripheral PulsesTimepoint: 45 Days
- Secondary Outcome Measures
Name Time Method To find out the efficacy of treatment in 30 patients with the help of PAIN VAS SCALE, Burning Sensation (Daha), Malaise (Angmarda), Local Colour Changes in the Skin & Tenderness (Sparshasahyata), Edema (Shwayathu), Walking Ability, Peripheral Pulses.Timepoint: 45 days